Evidence – Using CRISPR Screening to Decode Tumour Microenvironment Biology & Identify Next Generation Immunotherapy Targets

Name: Evidence – Using CRISPR Screening to Decode Tumour Microenvironment Biology & Identify Next Generation Immunotherapy Targets
Start: 2026-12-02T16:00
Location: Hilton London Canary Wharf

Tumour Models London Summit 2026 · 2 December 2026 · 16:00

Evidence – Using CRISPR Screening to Decode Tumour Microenvironment Biology & Identify Next Generation Immunotherapy Targets was a session at Tumour Models London Summit 2026 on 2 December 2026 in London, with 1 speaker on record.

Speakers

Romain Lara — Speaker Associate Director, AstraZeneca